Furthermore, the study by Halama, N. et al. confirmed that inhibition of CCR5 can repolarize TAMs from M2 to M1 through regulation of the STAT3/SOCS3 signaling pathway in TAMs, showing the anticancer effects in patients with liver metastases from CRC [207]. The gene discussed is STAT3; the disease is colorectal carcinoma.